Everolimus in Treating Patients With Stage IV Melanoma
Study Information
Alliance Study ID: NCCTG-N0377
NCT Study ID (ClinicalTrials.gov): NCT00098553
Disease or Cancer Type: Melanoma & Skin Cancers
Alliance Study Chair: Ravi D. Rao, MD, MBBS
Status: COMPLETED
Study Description
RATIONALE: Drugs used in chemotherapy, such as everolimus, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Everolimus may also stop the growth of melanoma by blocking blood flow to the tumor.
PURPOSE: This phase II trial is studying how well everolimus works in treating patients with stage IV melanoma.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information